Dynatrace heads into its August 10 earnings date with one of the more bullish analyst backdrops in the application software space — and a stock that has only just begun to price it in.
The analyst story is the standout this week. DA Davidson raised its target to $60 on Tuesday, up from $45, maintaining Buy. That follows Truist Securities lifting to $55 last week and Goldman Sachs moving to $50 in mid-June. UBS is arguably the most striking move in the recent run: the firm upgraded from Neutral to Buy on June 16 and nearly doubled its target to $60 from $36. Taken together, the direction of travel on the Street is unambiguously higher — the mean target has climbed to $46.24 against a current price of $45.04, meaning the consensus has essentially caught up with the stock after its 10.5% gain over the past month. Bulls point to a 3-4x surge in platform customers, accelerating ARR guidance, and a strong FY27 pipeline. The lone dissenter in recent weeks is Needham, which reiterated Hold with no target in late June — a reminder that not every analyst is chasing the momentum.
The broader positioning picture is relaxed rather than charged. Short interest is running at 3.3% of the free float, up around 5% on the week but still a level that implies no meaningful bearish conviction from professional sellers. Borrow costs have crept up roughly 19% over the past week to 0.53% — notable as a directional signal, but still extremely cheap in absolute terms. Availability is vast, with over 2,800% of current short interest available to borrow, meaning the lending pool is nowhere near stressed. That combination — rising short interest, rising CTB, but abundant availability — reads as cautious sentiment building rather than any squeeze dynamic. Options reinforce the calm: the put/call ratio is 0.32, fractionally below its 20-day average of 0.33, and the z-score of -0.70 puts it well within the normal range. There is no unusual hedging demand ahead of August.
The factor picture supports the bull case on several fronts. The analyst recommendation differential ranks in the 94th percentile — one of the strongest readings across the ORTEX universe, consistent with the wave of upgrades described above. Forward earnings momentum ranks in the 73rd percentile on a 12-month basis, and EPS momentum scores are solid in the mid-to-upper 50s on both 30- and 90-day horizons. The short score, at 32.9, is benign and has barely moved this week despite the tick up in short interest. Valuation is less comfortable: at a P/E of around 19x and EV/EBITDA near 14x, the stock is not obviously cheap, and the bears' case rests partly on a history of missing consensus estimates — the EPS surprise factor ranks only in the 24th percentile, a meaningful counterpoint to the otherwise constructive setup.
Earnings history adds one more layer of nuance worth tracking. The most recent print in May produced a 5.3% one-day decline, though the stock recovered to a 1.7% gain over the following five days. The prior event showed a 7.4% single-day gain extending to 11% over the week. The pattern is binary and volatile — the stock has swung hard in both directions depending on the specific revenue retention and ARR figures delivered. With the mean analyst target now sitting only $1.20 above the current price, the Street's enthusiasm is already largely reflected in the level; August 10 is where DT will need the numbers to justify the upgrade cycle rather than simply sustain it.
What to watch: whether short interest continues building into the August print, and whether any of the recently upgraded analysts — particularly UBS or Goldman — adjust their targets further if the stock clears $46 on volume ahead of earnings.
See the live data behind this article on ORTEX.
Open DT on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
